Full-Time

Territory Sales Executive

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Mid, Senior

Company Historically Provides H1B Sponsorship

West Palm Beach, FL, USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Salesforce
Customer Service
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

You match the following Tempus's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Ability to provide an integrated MolDx/SaaS solution using Tempus’s sequencing technology to prospects and customers.
  • Ability to engage in a consultative selling process that overcomes objections and indifferences while connecting client needs with Tempus’ capabilities.
  • Comfortable selling at the executive level (CEO, COO, CFO)
  • Keen understanding of the payor and reimbursement environment in the oncology and diagnostic space
  • Ability to work independently, communicate proactively, manage multiple projects and prioritize daily tasks while managing critical deadlines
  • Strong understanding of molecular diagnostics for oncology and the evolving competitive landscape
  • Ability to maintain an outstanding level of market, customer, distribution and product knowledge necessary to accomplish sales and marketing objectives
  • Excellent knowledge of oncology, hematology, chemotherapeutics and targeted agents
  • Excellent negotiation and customer service skills
  • Outstanding strategic sales account planning skills
  • Superior listening and problem solving skills
  • Ability to handle sensitive information and maintain a very high level of confidentiality
  • Demonstrate consistent closing abilities throughout the sales cycle
  • Possess a very positive attitude and an understanding of the dynamics involved with organizational growth and change
  • Impeccable oral and verbal communication and presentation skills
  • Must be very proficient with all Microsoft Office products – particularly Excel and PowerPoint
  • Effective and regular utilization of Salesforce.com
  • Ability to develop and utilize cross-functional relationships to facilitate the accomplishment of work goals and objectives.
  • Advanced presentation skills and business acumen a necessity
  • Ability to work effectively with minimal direction from, or interface with, manager
  • Problem solving, decision making and technical learning
  • Advanced written and oral communication skills
  • Strong administrative skills and sophistication to manage business in complex environments
  • Demonstrate Tempus’ Values by acting with integrity, respect and trust
  • Frequent travel ( > 50%) throughout the territory as needed
Responsibilities
  • Drive strategic business expansion/collaboration opportunities with the following: Major U.S. cancer centers and clinics / Top 20 largest oncology practices in the territory, Key Opinion Leaders (KOLs) and Academic Medical Centers (AMCs) within the specified territory.
  • Structure detailed strategic plans for gaining and retaining new and existing clients.
  • Maximize client-bill contracting opportunities
  • Implement laboratory services agreements (LSA’s) with bill account institutions
  • Collaborate and coordinate with all sales positions (VP, Sales, RSD’s, DSM’s, SAM’s, and GL’s) to ensure successful attainment of company goals and objectives
  • Identify and develop partnering opportunities between prospective oncology clients and Tempus.
  • Promote and drive compliance with new web-based molecular information tools for all clients
  • Continually analyze competitive landscape and environment within assigned accounts to determine trends and provide customer feedback to Tempus leadership
  • Monitor performance of sales to ensure objectives are met
  • Develop and implement a comprehensive business plan for the territory that will be inclusive of budgets, travel, territory management, goal setting, etc.
  • Work effectively with individuals across multiple departments throughout Tempus
  • Embrace, embody and represent the Tempus company culture at all times to external and internal constituents.
Desired Qualifications
  • MBA preferred
  • 2-3 years of direct account management experience in a molecular diagnostic setting with a history of proven past performance that has met and exceeded expectations.
  • Candidate must have 3-5 years of experience working with major cancer centers and clinics, oncology GPO’s, large health systems, IHDN’s, and large oncology practices.
  • Demonstrated measurable revenue generation at either a diagnostic, pharmaceutical or relevant biotechnology company.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus also conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Unlike many competitors, Tempus combines extensive data analysis with a focus on personalized medicine, aiming to improve care and treatment options for patients.

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus' AI platform aids in personalized cancer treatment and drug development.
  • The Olivia app empowers patients with AI-driven health management tools.
  • Partnerships with firms like Genialis expand Tempus' diagnostic capabilities.

What critics are saying

  • Over-reliance on AI may lead to misinterpretation of medical data.
  • Data privacy concerns arise with the Olivia app's extensive health system integration.
  • Regulatory challenges may hinder the global rollout of Tempus' xT CDx test.

What makes Tempus unique

  • Tempus uses AI to provide personalized treatment insights for cancer patients.
  • Their platform integrates clinical and molecular data for precision medicine.
  • Tempus collaborates with biotech firms to enhance drug development and diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

1%
Hit Consultant
Feb 21st, 2025
Stemline Therapeutics To Deploy Tempus Next’S Ai-Enabled Care Pathway Intelligence Platform

Stemline Therapeutics to Deploy Tempus Next’s AI-Enabled Care Pathway Intelligence Platform. by Fred Pennic 02/21/2025 Leave a Comment. What You Should Know: – Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing in metastatic breast cancer (mBC). – The partnership will leverage Tempus’ Next platform, an AI-enabled care pathway intelligence tool, to help clinicians determine when ESR1 testing may be appropriate for their patients.Challenges in ESR1 TestingESR1 mutations are a critical factor in the progression of ER+/HER2- mBC, a common type of breast cancer. Up to 50% of patients with this type of cancer can develop ESR1 mutations after prior endocrine therapy. Recognizing this, the American Society of Clinical Oncology (ASCO) recommends ESR1 mutation testing at each disease progression. Tempus Next: Guiding Clinical DecisionsTempus’ Next platform will analyze clinical data from mBC patients and notify clinicians when ESR1 testing is missing at disease progression

ETF Daily News
Feb 15th, 2025
Apollon Wealth Management LLC Makes New $256,000 Investment in Tempus AI, Inc. (NASDAQ:TEM)

Apollon Wealth Management LLC makes new $256,000 Investment in Tempus AI, Inc. (NASDAQ:TEM).

Money Morning
Feb 14th, 2025
Nancy Pelosi's Favorite AI Stock Rising Again After 13% Surge

Tempus announced yesterday that it was collaborating with the nonprofit Institute for Follicular Lymphoma Innovation to develop treatment options for patients with the disease.

Medical Device Network
Feb 13th, 2025
Artera partners with Tempus to expand AI cancer test access

Currently connected to more than 50% of all oncologists practising in the US, Chicago-based Tempus will work with Artera on an exclusive basis to commercialise the latter's ArteraAI prostate test.

TipRanks
Feb 13th, 2025
Tempus AI enters collaboration with Institute for Follicular Lymphoma Innovation

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation.